Hellesnes, Ragnhild <br/><br/>
Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.  [electronic resource] 

 -  International journal of cancer  07 2020 
 - 21-32 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.32704  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cisplatin--administration & dosage<br/>Cohort Studies<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Neoplasms, Germ Cell and Embryonal--drug therapy<br/>Neoplasms, Second Primary--epidemiology<br/>Norway--epidemiology<br/>Registries<br/>Risk<br/>Testicular Neoplasms--drug therapy<br/>Young Adult